TABLE 1.
Vial no. | Virus | No. of HSV GE/ml | No. of positive results/no. of testsa |
---|---|---|---|
1 | None | 0/7 | |
2 | HSV-1 | 2 × 104–5 × 104 | 7/7 |
3 | HSV-2 | 2 × 103–5 × 103 | 1/7 |
4 | HSV-1 | 2 × 102–5 × 102 | 3/7 |
5 | HSV-1 | 2 × 105–5 × 105 | 7/7 |
6 | HSV-2 | 2 × 106–5 × 106 | 7/7 |
7 | HSV-1 | 2 × 103–5 × 103 | 7/7 |
8 | None | 0/7 | |
9 | HSV-2 | 2 × 105–5 × 105 | 6/7 |
10 | HSV-2 | 2 × 104–5 × 104 | 6/7 |
11 | VZV | 0/7 | |
12 | HSV-1 | 0.7 × 103–1.7 × 103 | 5/7 |
Panel tested by six reference laboratories using a total of seven different molecular methods before distribution.